DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Tong H, Fan Z, Liu B, Lu T.
The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis.
Sci Rep 2018;
8 (01) 8666
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.